Urinary excretion of endothelin-1 (ET-1), transforming growth factor-β1 (TGF-β1) and vascular endothelial growth factor (VEGF 165) in paediatric chronic kidney diseases: Results of the ESCAPE trial

Nephrology Dialysis Transplantation

Volumn 22, Issue 12, 2007, Pages 3487-3494

  Grenda, Ryszard ^a   Wühl, Elke ^b   Litwin, Mieczysław ^a   Janas, Roman ^a   Śladowska, Joanna ^a   Arbeiter, Klaus ^c   Berg, Ulla ^d   Caldas Afonso, Alberto ^e   Fischbach, Michel ^f   Mehls, Otto ^b   Sallay, Peter ^g   Schaefer, Franz ^b  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e HOSPITAL DE SÃO JOÃO   (Portugal)

^f HÔPITAL DE HAUTEPIERRE   (France)

^g SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Adolescents; Children; Chronic kidney disease; ET 1; TGF 1; Urinary biomarkers excretion; VEGF165

Indexed keywords

CREATININE; ENDOTHELIN 1; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN 165;

ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE MARKER; FEMALE; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; KIDNEY HYPOPLASIA; KIDNEY INJURY; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NEPHRONOPHTHISIS; OBSTRUCTIVE UROPATHY; PRIORITY JOURNAL; PROTEINURIA; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; URINALYSIS; URINARY EXCRETION;

CHILD; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; ENDOTHELIN-1; HUMANS; KIDNEY DISEASES; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 36749090703     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm300     Document Type: Article

References (45)

1. Benigni A, Zoja C, Corna D et al. A specific subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993; 44: 440-444
2. Kohan DE. Endothelins in the normal and diseased kidney. Am J Kidney Dis 1997; 29: 2-26
3. Yanashigawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1998; 332: 411-415
4. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 1990; 348: 730-732
5. Hunley TE, Kon V. Update of endothelins: biology and clinical implications. Pediatr Nephrol 2001; 16: 752-762
6. Border WA, Noble NA. TGF-β1 in kidney fibrosis: a target for gene therapy. Kidney Int 1997; 51: 1388-1396
7. Border WA, Noble NAL. Interactions of transforming growth factor β and angiotensin II in renal fibrosis. Hypertension 1998; 31: 181-188
8. Murakami K, Takamura T, Hino S, Yoshioka K. Urinary transforming growth factor β1 in patients with glomerular diseases. Pediatr Nephrol 1997; 11: 334-336
9. Böttinger EP, Bitzer M. TGF-β signaling in renal disease. J Am Soc Nephrol 2002; 13: 2600-2610
10. Ferrara N, Houck KA, Jakeman LB et al. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991; 47: 211-218
11. Kang DH, Kanellis J, Hugo C et al. Role of microvascular endothelium in progressive renal disease. J Am Soc Nephrol 2002; 13: 806-816
12. Bartels H, Bohmer M. Eine mikrometode zur kreatinin bestimmung. Clin Chim Acta 1971; 32: 81-85
13. Schwartz GJ, Haycock GB, Edelmann CMJr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilising the principle of protein - dye binding. Anal Biochem 1976; 72: 248-254
15. Worgall S, Manz F, Kleschin K, Feth F, Rascher W. Elevated urinary excretion of endothelin-like immunoreactivity in children with renal disease is related to urine flow rate. Clin Nephrol 1994; 41: 331-337
16. Cantaro S, Milan Manani S, Marcon R et al. Urinary excretion of vasoactive substances in chronic renal failure. Clin Nephrol 2001; 55: 393-399
17. Roccatello D, Mosso R, Ferro M et al. Urinary endothelin-1 in glomerulonephritis patients with normal renal function. Clin Nephrol 1994; 41: 323-330
18. Wolf SC, Smoltczyk H, Brehm BR, Erley CM, Risler T. Endothelin-1 and endothelin-3 levels in different types of glomerulonephritis. J Cardiovasc Pharmacol 1998; 31: S482-S485
19. Vlachojannis JG, Tsakas S, Petropoulou C, Goumenos DS, Alexandri S. Endothelin-1 in the kidney and urine of patients with glomerular disease and proteinuria. Clin Nephrol 2002; 58: 337-343
20. Ohta K, Hirata Y, Shichiri M et al. Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int 1991; 39: 301-311
21. Takeda M, Komeyama T, Katayama Y et al. Measurment of urinary endothelin-1-like immunoreactivity and comparison with other urinary parameters in patients with primary vesicoureteral reflux. Eur Urol 1994; 25: 326-320
22. Taha MA, Shokeir AA, Osman HG, El-Aziz A, Farahat SE. Diagnosis of ureteropelvic junction obstruction in children: role of endothelin-1 in voided urine. Urology 2007; 69: 560-565
23. Honkanen E, Teppo A-M, Törnroth T, Groop PH, Grönhagen-Riska C. Urinary transforming β1 in membranous glomerulonephritis. Nephrol Dial Transplant 1997; 12: 2562-2568
24. De Muro P, Faedda R, Fresu P et al. Urinary transforming growth factor β1 in various types of nephropathy. Pharmacol Res 2004; 49: 293-209
25. Goumenos DS, Tsakas S, El Nahas AM et al. Transforming growth factor-β1 in the kidney and urine of patients with glomerular disease and proteinuria. Nephrol Dial Transplant 2002; 17: 2145-2152
26. Korpinen E, Teppo A-M, Hukkanen L, Akerblom H, Gronhagen-Riska C, Vaarala O. Urinary transforming growth factor-β1 and α1-macroglobulin in children and adolescents with type-1 diabetes. Diabetes Care 2000; 23: 664-668
27. + exchange activity. Kidney Int 1998; 53: 1601-1607
28. Gekle M, Knaus P, Nielsen R et al. Transforming growth factor-β1 reduces megalin- and cubilin-mediated endocytosis of albumin in proximal tubule-derived opossum kidney cells. J Physiol 2003; 552: 471-481
29. Taha MA, Shokeir AA, Osman HG, El-Aziz A, Farahat SE. Pelvi-ureteric junction obstruction in children: the role of transforming growth factor-β and epidermal growth factor. BJU Int 2007; 99: 899-903
30. Furness PD, Maizels M, Han SW, Cohn RA, Cheng EY. Elevated bladder urine concentration of transforming growth factor- beta1 correlates with upper urinary tract obstruction in children. J Urol 1999; 162: 1033-1036
31. El-Sherbiny MT, Mousa OM, Shokeir AA, Ghoneim MA. Role of urinary transforming growth factor- beta1 concentration in the diagnosis of upper urinary tract obstruction in children. J Urol 2002; 168: 1798-1800
32. Palmer LS, Maizels M, Kaplan WE, Firlit CF, Cheng EY. Urine levels of transforming growth factor- beta1 in children with ureteropelvic junction-obstruction. J Urol 1997; 50: 769-773
33. Monga M, Gabal-Shehab LL, Stein P. Urinary transforming growth factor- beta1 levels correlated with bladder outlet obstruction. Int J Urol 2001; 8: 487-489
34. MacRae Dell K, Hoffman BB, Leonard MB, Ziyadeh FN, Schulman SL. Increased urinary transforming growth factor- beta1 excretion in children with posterior urethral valve. Urology 2000; 56: 311-314
35. Maruyama T, Hayashi Y, Nakane A, Sasaki S, Kohri K. Intermittent pressure-loading increases transforming growth factor-beta-1 secretion from renal tubular epithelial cells: in vitro vesicoureteral reflux model. Urol Int 2005; 75: 150-158
36. Sutaria PM, Ohebshalom M, McCaffrey TA, Vaughan ED, Felsen D. Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral obstruction. Life Sci 1998; 62: 1965-1972
37. Misseri R, Rink RC, Meldrum DR, Meldrum KK. Inflammatory mediators and growth factors in obstructive renal injury. J Surg Res 2004; 119: 149-159
38. Miyajuma A, Chen J, Lawrence C et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 2000; 58: 2301-2310
39. Matsumoto K, Kanmatsuse K. Elevated vascular endothelial growth factor levels in the urine of patients with minimal change nephrotic syndrome. Clin Nephrol 2001; 55: 269-274
40. Honkanen EO, Teppo AM, Gronhagen-Riska C. Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis. Kidney Int 2000; 57: 2343-2340
41. Kitamoto Y, Matsuo K, Tomita K. Different response of urinary excretion of VEGF in patients with chronic and acute renal disease. Kidney Int 2001; 59: 385-386
42. Burt LE, Forbes MS, Thornhill BA, Kiley SC, Chevalier RL. Renal vascular endothelial growth factor in neonatal obstructive nephropathy. I. Endogenous VEGF. Am J Pysiol Renal Physiol 2007; 292: F158-F167
43. Ohashi R, Shimizu A, Masuda Y et al. Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol 2002; 13: 1795-1805
44. Nakagawa T, Lan HY, Zhu HJ, Kang DH, Schreiner GF, Johnson RJ. Differential regulation of VEGF by TGFβ and hypoxia in rat proximal tubular cells. Am J Physiol Renal Physiol 2004; 287: F658-F664
45. Kitamura S, Maeshima Y, Sugaya T, Sugiyama H, Yamasaki Y, Makino K. Transforming growth factor β1 induces cascular endothelial growth factor espression in murine proximal tubular epithelial cells. Nephron Exp Nephrol 2003; 95: 79-86